Cannabis has incredible effects that can vastly improve lives, but we believe that its full potential has yet to be unlocked. That’s why we’ve created a unique holistic business model that takes complete control of the process – from research, through growth, to consumption – creating an innovative and precise product that has the power to change the lives of millions.
Launch of Treat It
Acquisition of GP Service
Launch of Kanabo.store
MoU to distribute CBD in Israel with Forbe, Ltd
First medical cannabis company approved to list on London Stock Exchange
Successful RTO listing of Kanabo Group, Plc on London Stock Exchange
UK medical cannabis distribution agreement with Lyphe Group
EU GMP CBD manufacturing agreement with Pure Origin
First commercial scale production for CBD wellness
First medical cannabis product in UK
Pre-IPO investment and a strategic MoU partnership with Hellenic Dynamics
Patent for sleep disorders matured to national phase
Distribution agreements for CBD wellness product line in UK
German distribution agreement signed
Submitted Non-THC provisional patent
OTC formulations Focus, Serenity & Revive developed
Submitted PCT patents for Sleep formulation
Final approval of the VapePod as a medical device for trials in Israel
Final licence approval for Cannabis R&D activities, extraction and pre-clinical studies
Pre-clinical trials of Kanabo’s THC formulation for sleep disorders completed
Kanabo Research Ltd. founded in Israel
Secured partnership with Jupiter Research for VapePod
Start of work in R&D lab in the Weizmann Science Park, Israel